Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients (Q39551843)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 September 2012

Language	Label	Description	Also known as
English	Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients	scientific article published on 16 September 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Liang Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Zhong-jun Xia

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Hui-qiang Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yue Lu

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yu-jing Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

16 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

617-623

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Extranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Prospects for pirarubicin

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1174-Y

21 January 2018

A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983648

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983648

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983648

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983648

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983648

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-012-1174-Y

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

release_obj5a4zonnhznl2z5fxerapdui

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39551843&oldid=2202972128"